Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

ICON GeneesmiddelenonderzoekICON Geneesmiddelenonderzoek
VS
MerckMerck
ICON Geneesmiddelenonderzoek

ICON Geneesmiddelenonderzoek

Van Swietenlaan 6, Groningen, Nederland, NL, 9728 NZ

Last Update: 08/11/2025

View Profile
Between 750 and 799
https://www.geneesmiddelenonderzoek.nl/
750/1000Fair

ICON is wereldleider op het gebied van geneesmiddelenonderzoek. In opdracht van farmaceutische bedrijven doen we onafhankelijk onderzoek naar de werking van innovatieve, nieuwe of verbeterde geneesmiddelen bij mensen. In Nederland verrichten we met name klinisch en bioa...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14
Subsidiaries:9
12-month incidents
0
Known data breaches
0
Attack type number
0
Merck

Merck

126 E Lincoln Ave, P.O. Box 2000, Rahway, New Jersey, US, 07065

Last Update: 05/07/2026

View Profile
Between 800 and 849
http://merck.us/2J2xAUh
802/1000Good

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of i...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:44,762
Subsidiaries:2
12-month incidents
0
Known data breaches
1
Attack type number
2

Compliance Ranges Comparison

Based On Specific Ai Models Category
ICON Geneesmiddelenonderzoek

ICON Geneesmiddelenonderzoek

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Merck

Merck

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for ICON Geneesmiddelenonderzoek in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck in 2026.

Incidents

Incident History - ICON Geneesmiddelenonderzoek (X = Date, Y = Severity)

ICON Geneesmiddelenonderzoek cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Merck (X = Date, Y = Severity)

Merck cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
ICON Geneesmiddelenonderzoek

ICON Geneesmiddelenonderzoek

Incidents
No explicit notable incidents reported.
Merck

Merck

Incidents
🔒 Incident : Breach
MER3502435111825
🔒 Incident : Cyber Attack
MER1775377932
🔒 Incident : Cyber Attack
MER1502422

FAQ

Between ICON Geneesmiddelenonderzoek company and Merck company, which one has the best AI Cybersecurity Score ?
Between ICON Geneesmiddelenonderzoek company and Merck company, which one has experienced more cyber incidents in the past ?
Between ICON Geneesmiddelenonderzoek company and Merck company, which one has experienced more cyber incidents this year ?
Between ICON Geneesmiddelenonderzoek company and Merck company, which one has experienced at least one ransomware attack ?
Between ICON Geneesmiddelenonderzoek company and Merck company, which one has experienced at least one data breach ?
Between ICON Geneesmiddelenonderzoek company and Merck company, which one has experienced at least one targeted cyberattack ?
Between ICON Geneesmiddelenonderzoek company and Merck company, which one has experienced at least one vulnerability ?
Between ICON Geneesmiddelenonderzoek company and Merck company, which one holds the most compliance certifications ?
Between ICON Geneesmiddelenonderzoek company and Merck company, which one holds the fewest compliance certifications ?
Between ICON Geneesmiddelenonderzoek company and Merck company, which one has the most subsidiaries ?
Between ICON Geneesmiddelenonderzoek company and Merck company, which one has the largest number of employees ?
Between ICON Geneesmiddelenonderzoek and Merck, which company holds both SOC 2 Type 1 certifications ?
Between ICON Geneesmiddelenonderzoek and Merck, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - ICON Geneesmiddelenonderzoek or Merck ?
Which company is PCI DSS compliant - ICON Geneesmiddelenonderzoek or Merck ?
Between ICON Geneesmiddelenonderzoek and Merck, which company complies with HIPAA regulations for healthcare data ?
Between ICON Geneesmiddelenonderzoek and Merck, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
REFERENCES